175 related articles for article (PubMed ID: 32585492)
1. Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease.
Dicks E; van der Flier WM; Scheltens P; Barkhof F; Tijms BM;
Neurobiol Aging; 2020 Oct; 94():71-80. PubMed ID: 32585492
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
3. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.
Ossenkoppele R; Mattsson N; Teunissen CE; Barkhof F; Pijnenburg Y; Scheltens P; van der Flier WM; Rabinovici GD
Neurobiol Aging; 2015 Aug; 36(8):2340-7. PubMed ID: 25990306
[TBL] [Abstract][Full Text] [Related]
5. Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.
Tucholka A; Grau-Rivera O; Falcon C; Rami L; Sánchez-Valle R; Lladó A; Gispert JD; Molinuevo JL;
J Alzheimers Dis; 2018; 61(4):1575-1587. PubMed ID: 29376852
[TBL] [Abstract][Full Text] [Related]
6. Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.
Cantero JL; Atienza M; Sanchez-Juan P; Rodriguez-Rodriguez E; Vazquez-Higuera JL; Pozueta A; Gonzalez-Suarez A; Vilaplana E; Pegueroles J; Montal V; Blesa R; Alcolea D; Lleo A; Fortea J
Neurobiol Aging; 2018 Apr; 64():58-67. PubMed ID: 29331877
[TBL] [Abstract][Full Text] [Related]
7. Selective disruption of the cerebral neocortex in Alzheimer's disease.
Desikan RS; Sabuncu MR; Schmansky NJ; Reuter M; Cabral HJ; Hess CP; Weiner MW; Biffi A; Anderson CD; Rosand J; Salat DH; Kemper TL; Dale AM; Sperling RA; Fischl B;
PLoS One; 2010 Sep; 5(9):e12853. PubMed ID: 20886094
[TBL] [Abstract][Full Text] [Related]
8. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
Kimura A; Yoshikura N; Hayashi Y; Inuzuka T
J Alzheimers Dis; 2018; 61(2):581-588. PubMed ID: 29171996
[TBL] [Abstract][Full Text] [Related]
10. Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study.
Wan K; Yin W; Tang Y; Zhu W; Wang Z; Zhou X; Zhang W; Zhang C; Yu X; Zhao W; Li C; Zhu X; Sun Z
J Alzheimers Dis; 2023; 92(1):81-93. PubMed ID: 36710682
[TBL] [Abstract][Full Text] [Related]
11. Gray matter network disruptions and amyloid beta in cognitively normal adults.
Tijms BM; Kate MT; Wink AM; Visser PJ; Ecay M; Clerigue M; Estanga A; Garcia Sebastian M; Izagirre A; Villanua J; Martinez Lage P; van der Flier WM; Scheltens P; Sanz Arigita E; Barkhof F
Neurobiol Aging; 2016 Jan; 37():154-160. PubMed ID: 26559882
[TBL] [Abstract][Full Text] [Related]
12. Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers.
Montembeault M; Brambati SM; Lamari F; Michon A; Samri D; Epelbaum S; Lacomblez L; Lehéricy S; Habert MO; Dubois B; Kas A; Migliaccio R
Neuroimage Clin; 2018; 20():1018-1025. PubMed ID: 30340200
[TBL] [Abstract][Full Text] [Related]
13. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
14. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
15. Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease.
Tijms BM; Ten Kate M; Gouw AA; Borta A; Verfaillie S; Teunissen CE; Scheltens P; Barkhof F; van der Flier WM
Neurobiol Aging; 2018 Jan; 61():75-81. PubMed ID: 29040871
[TBL] [Abstract][Full Text] [Related]
16. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.
Phillips JS; Da Re F; Dratch L; Xie SX; Irwin DJ; McMillan CT; Vaishnavi SN; Ferrarese C; Lee EB; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
Neurobiol Aging; 2018 Mar; 63():75-87. PubMed ID: 29223682
[TBL] [Abstract][Full Text] [Related]
17. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
18. Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype.
Gispert JD; Rami L; Sánchez-Benavides G; Falcon C; Tucholka A; Rojas S; Molinuevo JL
Neurobiol Aging; 2015 Oct; 36(10):2687-701. PubMed ID: 26239178
[TBL] [Abstract][Full Text] [Related]
19. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
